Protein-Protein Interaction-based Novel Drugs Design Empowered by AI and Biophysics
Computation-Driven Drug Design
OUR MISSION
Bring Designer Molecules for 'undruggable’ Targets to Patients.
Al-driven drug discovery is a new digital and intelligent methodology that can "think out of the box", which is expected to solve "undruggable" or difficult to drug targets.

Next-gen Drug Discovery Platform

By integrating artificial intelligence (AI), biophysics with high-throughput experiments, neoX focuses on the research and development of macromolecular drugs and multi-specific drugs.

see more
neoBiologics
-cytokine, nanobody, novel protein drugs,etc.
  • Measure/Predict many critical properties that characterize therapeutic viability as early in the process as possible
  • Novel biological drugs are designed, evaluated, engineered from perspectives of dynamics, energetics and AI
neoDegraders
-PROTAC & Molecular Glue
  • Identifying the structure-activity relationship by ensemble of meta-stable structures
  • Novel degrader-induced protein-protein interaction (PPI) leads to the high-potency & high-selectivity by design, with the potential to become “first-in-class” & “best-in-class”

Contact

Beijing
6-608, PKUCare Industrial Park, Changping District
US
One Broadway, Cambridge, MA 02142
Shanghai
Floor 6, Shanghai iCampus, EDGE 88 Xizang North Road, Jing'an District
Partnering and collaboration: bd@neoxbio.com
Job opportunities: hr@neoxbio.com
Other: info@neoxbiotech.com